ES2194116T3 - Procedimiento para detectar anticuerpos antipolimero y kit de prueba de diagnostico para uso como ayuda al diagnostico de las enfermedades relacionadas con silicona. - Google Patents

Procedimiento para detectar anticuerpos antipolimero y kit de prueba de diagnostico para uso como ayuda al diagnostico de las enfermedades relacionadas con silicona.

Info

Publication number
ES2194116T3
ES2194116T3 ES96934107T ES96934107T ES2194116T3 ES 2194116 T3 ES2194116 T3 ES 2194116T3 ES 96934107 T ES96934107 T ES 96934107T ES 96934107 T ES96934107 T ES 96934107T ES 2194116 T3 ES2194116 T3 ES 2194116T3
Authority
ES
Spain
Prior art keywords
antibodies
silicone
antipolimero
diagnosis
help
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96934107T
Other languages
English (en)
Inventor
Robert F Garry
Scott A Tenenbaum
Douglas R Plymale
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tulane University
Original Assignee
Tulane University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tulane University filed Critical Tulane University
Application granted granted Critical
Publication of ES2194116T3 publication Critical patent/ES2194116T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545—Synthetic resin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2430/00—Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes
    • G01N2430/60—Synthetic polymers other than synthetic polypeptides as analytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA UN EQUIPO Y UN METODO DE ENSAYO PARA DETECTAR ENFERMEDADES RELACIONADAS CON LA SILICONA, FIBROMIALGIA Y SINDROME DE FATIGA CRONICA. LOS METODOS DE LA PRESENTE INVENCION COMPRENDEN A) PROPORCIONAR UNA MUESTRA A ENSAYAR CON UN ANTICUERPO ANTIPOLIMERICO Y B) COMBINAR UN POLIMERO SELECCIONADO DE ENTRE EL GRUPO QUE CONSTA DE POLIACRILAMIDA (EN PARTICULAR, POLIACRILAMIDA PARCIALMENTE POLIMERIZADA), SILICONA Y COLAGENO CON LA MUESTRA CITADA DURANTE UN TIEMPO SUFICIENTE PARA QUE EL ANTICUERPO ANTIPOLIMERICO REACCIONE CON EL POLIMERO CITADO PARA FORMAR UN COMPLEJO. SE AÑADE UN REACTIVO AL MATERIAL RESULTANTE DE LA ETAPA B) PARA INDICAR LA PRESENCIA O AUSENCIA DE UN ANTICUERPO ANTIPOLIMERICO EN LA MUESTRA CITADA.
ES96934107T 1995-10-20 1996-10-08 Procedimiento para detectar anticuerpos antipolimero y kit de prueba de diagnostico para uso como ayuda al diagnostico de las enfermedades relacionadas con silicona. Expired - Lifetime ES2194116T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/546,333 US5834215A (en) 1994-10-05 1995-10-20 Method for detecting antipolymer antibodies and diagnosing silicone related disease (SRD) fibromyalgia and chronic fatigue syndrome (CFS)

Publications (1)

Publication Number Publication Date
ES2194116T3 true ES2194116T3 (es) 2003-11-16

Family

ID=24179940

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96934107T Expired - Lifetime ES2194116T3 (es) 1995-10-20 1996-10-08 Procedimiento para detectar anticuerpos antipolimero y kit de prueba de diagnostico para uso como ayuda al diagnostico de las enfermedades relacionadas con silicona.

Country Status (9)

Country Link
US (1) US5834215A (es)
EP (1) EP0873518B1 (es)
JP (1) JP3630689B2 (es)
AT (1) ATE234466T1 (es)
AU (1) AU710252B2 (es)
CA (1) CA2235316C (es)
DE (1) DE69626683T2 (es)
ES (1) ES2194116T3 (es)
WO (1) WO1997014963A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
ITFI980099A1 (it) * 1998-04-27 1999-10-27 Univ Firenze Metodo diagnostico per patologie algiche
GB2368642B (en) * 1999-08-13 2004-07-07 David E Berg Method for detecting, treating, and monitoring conditions associated with activation of the coagulation response
US6692969B1 (en) 1999-08-13 2004-02-17 David E. Berg Method for detecting, treating, and monitoring conditions associated with activation of the coagulation response
DE60033665T2 (de) * 2000-10-31 2007-10-31 Micronas Gmbh Gemusterte Polymeroberflächen geeignet für Biokonjugationen und Verfahren zu ihrer Herstellung
US7178152B2 (en) * 2001-03-01 2007-02-13 Sony Corporation Application programming interface for communication between audio/video file system and audio video controller
WO2009085968A1 (en) * 2007-12-19 2009-07-09 Great Lakes Biosciences, Llc Brain-related chronic pain disorder diagnosis and assessment method
AU2007207089A1 (en) * 2006-01-18 2007-07-26 Wick, Immunologische Diagnostik U. Beratung Kg Test systems for the analysis of polypeptides and cells adhering to silicones
US8150526B2 (en) 2009-02-09 2012-04-03 Nano-Retina, Inc. Retinal prosthesis
US8706243B2 (en) 2009-02-09 2014-04-22 Rainbow Medical Ltd. Retinal prosthesis techniques
DE202010004193U1 (de) 2010-03-22 2011-05-05 Bieger, Wilfried P., Priv.-Doz. Dr.med.habil. Testbestecks zur Bestimmung von neuroregulatorischen und psychischen Störungen
DE102011005878A1 (de) 2010-03-22 2011-12-01 Wilfried P. Bieger Verfahren und Testbestecks zur Bestimmung von neuroregulatorischen und psychischen Störungen
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
WO2012046708A1 (ja) 2010-10-08 2012-04-12 Ａｘｉｓ株式会社 線維筋痛症の診断剤，診断方法及び治療剤
US8571669B2 (en) 2011-02-24 2013-10-29 Nano-Retina, Inc. Retinal prosthesis with efficient processing circuits
DE102012215515A1 (de) * 2012-08-31 2014-03-06 Klinikum Der Universität München Verfahren zur Detektion von Schäden an Silikonimplantaten und Computertomographiegerät
US9720477B2 (en) 2012-11-21 2017-08-01 Nano-Retina, Inc. Weak power supply operation and control
JP6674759B2 (ja) 2015-10-01 2020-04-01 国立大学法人北海道大学 線維筋痛症の判定のための方法及びキット
US10330686B2 (en) 2016-10-20 2019-06-25 Autoimmune Technologies, Llc Assay for anti-polyvinyl alcohol antibodies

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK169987D0 (da) * 1987-04-03 1987-04-03 Jens Christian Jensenius Human tumor-associated antigen, ca-ou1
US4918165A (en) * 1987-07-16 1990-04-17 Ophthalmic Research Corporation Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction
EP0324455A3 (en) * 1988-01-15 1991-03-27 Hans O. Ribi Novel polymeric immunological adjuvants
US5340720A (en) * 1989-11-29 1994-08-23 University Of Kansas Methods of diagnosing and monitoring rheumatic diseases
GB9204409D0 (en) * 1992-02-29 1992-04-15 Ciba Geigy Ag Determination method
WO1994020857A1 (en) * 1993-03-11 1994-09-15 The Regents Of The University Of California Assay for humoral immunity to macromolecules

Also Published As

Publication number Publication date
US5834215A (en) 1998-11-10
CA2235316C (en) 2005-12-20
AU710252B2 (en) 1999-09-16
DE69626683T2 (de) 2003-08-28
ATE234466T1 (de) 2003-03-15
AU7260496A (en) 1997-05-07
EP0873518B1 (en) 2003-03-12
WO1997014963A1 (en) 1997-04-24
EP0873518A1 (en) 1998-10-28
DE69626683D1 (de) 2003-04-17
JP3630689B2 (ja) 2005-03-16
CA2235316A1 (en) 1997-04-24
JPH11513802A (ja) 1999-11-24

Similar Documents

Publication Publication Date Title
ES2194116T3 (es) Procedimiento para detectar anticuerpos antipolimero y kit de prueba de diagnostico para uso como ayuda al diagnostico de las enfermedades relacionadas con silicona.
ES2160709T3 (es) Uso de lipocalina de neutrofilos humanos (hnl) como un marcador de diagnostico y preparacion de anticuerpo anti-hnl.
BR9917218A (pt) Anticorpos monoclonais, antìgenos, e diagnósticoe terapia de doenças malignas
ATE263377T1 (de) Vorrichtung für klinische analysen
DK1421215T3 (da) Fremgangsmåder til evaluering af patologiske tilstande under anvendelse af ekstracellulært RNA
PT821234E (pt) Suporte de teste diagnostico com um campo de teste multicamada e metodo para determinacao de substancias a analisar utilizando o mesmo
ATE488765T1 (de) Verfahren zum frühen nachweis einer nierenkrankheit und -verletzung
ATE132269T1 (de) Verfahren zur diagnose chronischer niedriger rückenschmerzen und nackenschmerzen
SE7906148L (sv) Forfarande for framstellning av en biologisk komposition for anvendning sasom referenskontroll vid diagnostiska tester
DE69510336D1 (de) Verfahren zur diagnose von praeklampsie
DE69531345D1 (de) Rekombinant pgp3, verfahren zu dessen herstellung, und dessen verwendung in der diagnose und therapie
PT946873E (pt) Metodos para diagnostico da aspergilose broncopulmonar alergica
BR9708421A (pt) Processo para a deteccão de doenca provocada por prions teste diagnostico ou kit de teste e uso do processo
PT909388E (pt) Ensaios imunologicos para encefalopatias espongiformes
DE69713146D1 (de) Helicobacter pylori diagnostika
ES2078733T3 (es) Metodo para la deteccion de anticuerpos anti-arn.
DK0764273T3 (da) Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose
EA199800959A1 (ru) ПРИМЕНЕНИЕ ГЕНЕТИЧЕСКОЙ МОДИФИКАЦИИ В ГЕНЕ b3- СУБЪЕДИНИЦЫ ЧЕЛОВЕЧЕСКОГО G-ПРОТЕИНА ДЛЯ ДИАГНОСТИКИ ЗАБОЛЕВАНИЙ
DE69132144D1 (de) Menschliche phospholipase aktivierender proteinteil
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
ATE154395T1 (de) Monoklonale antikörper
IT1283899B1 (it) Peptidi e loro usi nella terapia della malattia celiaca
ES2173146T3 (es) Ensayo inmunologico para la cuantificacion del factor humano de estimulacion de las colonias de granulocitos humanos modificados por peg.
ES2068863T3 (es) Deteccion inmunologica de atracina y de derivados de atracina.
DE60308328D1 (de) Vorrichtung zum hauttest